Mercury Laboratories Board of Directors
Get the latest insights into the leadership at Mercury Laboratories. Learn about the experienced professionals guiding the company's strategy and governance.
| Name | Position |
|---|---|
| Mr. Sanjay Patel | Chairperson & Independent Director |
| Mr. Rajendra R Shah | Managing Director |
| Ms. Janki R Shah | Non Executive Director |
| Mr. Paresh Mistry | Non Executive Director |
| Mr. Dilip R Shah | Non Executive Director |
| Mr. Jayantilal D Raval | Ind. Non-Executive Director |
Mercury Laboratories Share price
MERCURYLAB
837
2.00 (0.24%)Last updated on 4 Sep, 2025 | 15:29 IST
BUYSELL
Today's High
837.00
Today's Low
836.65
52 Week Low
736.00
52 Week High
1190.00
The current prices are delayed, login to your account for live prices
LoginMercury Laboratories FAQs
The board at Mercury Laboratories consists of experienced professionals, including Mr. Sanjay Patel , Mr. Rajendra R Shah , and others, overseeing the company’s strategic and corporate governance.
Directors at Mercury Laboratories are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.
As of the latest update, Mr. Sanjay Patel is the current chairman at Mercury Laboratories.
Executive directors at Mercury Laboratories are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.
Yes, Mercury Laboratories adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.
At Mercury Laboratories, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.